解説【LBA74】Zongertinib as first-line treatment in patients with advanced HER2-mutant NSCLC: Beamion LUNG 1 新野 祐樹 (国立がん研究センター中央病院)
解説【LBA75】Sevabertinib (BAY 2927088) in advanced HER2-mutant non-small cell lung cancer (NSCLC):Results from the SOHO-01 study 新野 祐樹 (国立がん研究センター中央病院)
解説【LBA5】Sacituzumab tirumotecan (sac-TMT) vs platinum-based chemotherapy in EGFR-mutated (EGFRm)non-small cell lung cancer (NSCLC) following progression on EGFR-TKIs: results from therandomized, multi-center phase III OptiTROP-Lung04 study 新野 祐樹 (国立がん研究センター中央病院)